Myeloid Leukemia

Methods and Protocols

  • Harry Iland
  • Mark Hertzberg
  • Paula Marlton

Part of the Methods In Molecular Medicine™ book series (MIMM, volume 125)

Table of contents

  1. Front Matter
    Pages i-xi
  2. Joop H. Jansen, Bert A. van der Reijden
    Pages 1-11
  3. Susan Branford, Timothy Hughes
    Pages 93-106
  4. Elisa Mokany, Alison V. Todd, Caroline J. Fuery, Tanya L. Applegate
    Pages 127-147
  5. Hitoshi Kiyoi, Tomoki Naoe
    Pages 189-197
  6. Daniela Cilloni, Enrico Gottardi, Giuseppe Saglio
    Pages 199-211
  7. Alexander Kohlmann, Wolfgang Kern, Wolfgang Hiddemann, Torsten Haferlach
    Pages 213-240
  8. Richard I. Christopherson, Kerryn Stoner, Nicole Barber, Larissa Belov, Adrian Woolfson, Mike Scott et al.
    Pages 241-251
  9. Peter J. Campbell, Linda M. Scott, Joanna E. Baxter, Anthony J. Bench, Anthony R. Green, Wendy N. Erber
    Pages 253-264
  10. Maurizio Martini, Luciana Teofili, Luigi M. Larocca
    Pages 265-273
  11. Back Matter
    Pages 297-306

About this book


The highly significant role that acquired genetic abnormalities play in the genesis, diagnosis, and management of hematological malignancies has become increasingly clear. Such abnormalities can serve as useful markers for initial diagnosis, accurate subclassification, and the evaluation of minimal residual disease, as well as providing critical targets for novel therapies. In Myeloid Leukemia: Methods and Protocols, a panel of internationally recognized research scientists and clinical investigators brings together a diverse collection of readily reproducible methods for identifying and quantifying a large number of specific genetic abnormalities associated with the broad spectrum of myeloid malignancies. The methods range from those that are of immediate clinical relevance to the investigation and management of patients with myeloid malignancies, to those that relate to recently identified genetic abnormalities of potential clinical significance. Highlights include techniques for the detection of BCR-ABL mutations and resistance to imatinib mesylate, detection of the FIP1L1-PDGFRA fusion in idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia, classification of AML by DNA-oligonucleotide microarrays, and detection of the V617F JAK2 mutation in myeloproliferative disorders. In addition to gene rearrangments, other prognostically relevant molecular lesions such as FLT3 mutations and WT-1 overexpression are covered. The protocols follow the successful Methods in Molecular Biology™ series format, each offering step-by-step laboratory instructions, an introduction outlining the principles behind the technique, lists of the necessary equipment and reagents, and tips on troubleshooting and avoiding known pitfalls.
Clinically relevant and highly practical, Myeloid Leukemia: Methods and Protocols offers cytogeneticists, hematologists, and oncologists cutting-edge laboratory techniques that can be rapidly implemented for the investigation and management of patients with myeloid malignancies.


DNA cell classification leukemia stem cell stem cell transplantation transplantation

Editors and affiliations

  • Harry Iland
    • 1
  • Mark Hertzberg
    • 2
  • Paula Marlton
    • 3
  1. 1.Institute of HaematologyRoyal Prince Alfred HospitalCamperdownAustralia
  2. 2.Haematology DepartmentWestmead HospitalWestmeadAustralia
  3. 3.Haematology DepartmentPrincess Alexandra HospitalBrisbaneAustralia

Bibliographic information

  • DOI
  • Copyright Information Humana Press 2006
  • Publisher Name Humana Press
  • eBook Packages Springer Protocols
  • Print ISBN 978-1-58829-485-2
  • Online ISBN 978-1-59745-017-1
  • Series Print ISSN 1543-1894
  • Series Online ISSN 1940-6037
  • Buy this book on publisher's site